Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model

References

• Bustamante B, Campos PE. Endemic sporotrichosis. Curr Opin Infect Dis 2001; 14: 145–149
   PubMed Web of Science ®Google Scholar
• Schubach A, Schubach TM, Barros MB, Wanke B. Cat-transmitted sporotrichosis, Rio de Janeiro, Brazil. Emerg Infect Dis 2005; 11: 1952–1954
   PubMed Web of Science ®Google Scholar
• Schubach AO, Schubach TM, Barros MB. Epidemic cat-transmitted sporotrichosis. N Engl J Med 2005; 353: 1185–1186
   PubMed Web of Science ®Google Scholar
• Barros MBL, Schubach AO, Francesconi-do-Valle AC, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Inf Dis 2004; 38: 529–535
   PubMed Web of Science ®Google Scholar
• Kauffman CA. Sporotrichosis. Clin Inf Dis 1999; 29: 231–237
   PubMedGoogle Scholar
• Barros MBL, Schubach AO, Gutierrez-Galhardo MC, et al. Sporotrichosis with widespread cutaneous lesions: a report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil. Int J Dermatol 2003; 42: 677–681
   Google Scholar
• Barros MBL, Schubach TMP, Galhardo MCG, et al. Sporotrichosis: an emergent zoonosis in Rio de Janeiro. Mem Inst Oswaldo Cruz 2001; 96: 777–779
   PubMedGoogle Scholar
• Tachibana T, Matsuyama T, Mitsuyama M. Characteristic infectivity of Sporothrix schenckii to mice depending on routes of infection and inherent fungal pathogenicity. Med Mycol 1998; 36: 21–27
   Web of Science ®Google Scholar
• Lima R F, Schaffer GV, Borba CM. Variants of Sporothrix schenckii with attenuated virulence for mice. Micro Infect 2003; 5: 933–938
   Google Scholar
• Hogan LH, Klein BS, Levitz SM. Virulence factors of medically important fungi. Clin Microbiol Rev 1996; 9: 469–488
   PubMed Web of Science ®Google Scholar
• Lima O, Figueiredo CC, Previato JO, et al. Involvement of fungal cell wall components in adhesion of Sporothrix schenckii to human fibronectin. Infect Immun 2001; 69: 6874–6880
   PubMed Web of Science ®Google Scholar
• Carlos IZ, Sgarbi DBG, Santos GC, Placeres MCP. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumor necrosis factor-alfa. Scand J Immunol 2003; 57: 214–220
   PubMed Web of Science ®Google Scholar
• Nascimento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol Med Microbiol 2005; 43: 241–247
   PubMedGoogle Scholar
• Carlos IZ, Sgarbi DBG, Angluster J, Alviano CA, Silva CL. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia 1992; 117: 139–144
   Google Scholar
• Carlos IZ, Zini MMC, Sgarbi DBG, et al. Disturbances in the production of interleukin-1 tumor and necrosis factor in disseminated murine sporotrichosis. Mycopathologia 1994; 127: 189–194
   PubMed Web of Science ®Google Scholar
• Shiraishi A, Nakagaki K, Arai T. Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 1992; 120: 15–21
   PubMedGoogle Scholar
• Dickerson CL, Taylor RL, Drutz DJ. Susceptibility of congenitally athymic (nude) mice to sporotrichosis. Infect Immun 1983; 40: 417–420
   PubMedGoogle Scholar
• Ware AJ, Cockerell CJ, Skiest DJ, Kusmann HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am Acad Dermatol 1999; 40: 350–355
   PubMed Web of Science ®Google Scholar
• Carvalho MTM, Castro AP, Baby C, et al. Disseminated cutaneous in a patient with AIDS: report of a case. Rev Soc Bras Med Trop 2002; 35: 655–659
   PubMedGoogle Scholar
• Kajiwara H, Saito M, Ohga S, Uenotsuchi T, Yoshida SI. Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease. Inf Immun 2004; 72: 5073–5079
   PubMedGoogle Scholar
• Calich VLG, Purchio A, Paula CR. A new fluorescent viability test for fungi cells. Mycopathologia 1978; 66: 175–177
   Web of Science ®Google Scholar
• Fernandes KSS, Mathews HL, Bezerra LML. Differences in virulence of Sporothrix schenckii conidia related to culture conditions and cell-wall components. J Med Microbiol 1999; 48: 195–203
   Google Scholar
• Bertho AL, Santiago MA, Coutinho SG. An experimental model of the production of metastases in murine cutaneous leishmaniasis. J Parasitol 1994; 80: 93–99
   Google Scholar
• Pelzer K, Tietz HJ, Sterry W, Haas N. Isolation of both Sporothrix schenckii and Nocardia asteroides from a mycetoma of the forefoot. Br J Dermatol 2000; 143: 1311–1315
   Google Scholar
• Nobre MO, Antunes TA, Faria RO, et al. Differences in virulence between isolates of feline sporotrichosis. Mycopathologia 2005; 160: 43–49
   Google Scholar
• Staib F, Randhawa HS, Blisse A. Observations on experimental sporotrichosis of the muscle. Zbl Bakt Hyg, I Abt Orig A 1972; 221: 250–256
   Google Scholar
• Kurokawa CS, Sugizaki MF, Peraçoli MTS. Virulence factors in fungi of systemic mycoses. Rev Inst Med Trop S Paulo 1998; 40: 125–135
   PubMedGoogle Scholar
• Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis 1979; 139: 424–431
   PubMed Web of Science ®Google Scholar
• Langfelder K, Streibel M, Jahn B, Haase G, Brakhage AA. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Gen Biol 2003; 38: 143–158
   PubMed Web of Science ®Google Scholar
• Moris-Jones R, Youngehim S, Gomez BL, et al. Synthesis of melanin- like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect Immun 2003; 71: 4026–4033
   Google Scholar
• Figueiredo CC, Lima OC, Carvalho L, Lopez-Bezerra LM, Morandi V. The in vitro interaction of Sporothrix schenckii with human endothelial cells is modulated by cytokines and involves endothelial surface molecules. Micro Pathol 2004; 36: 177–188
   PubMed Web of Science ®Google Scholar
• Hachisuka H, Sasai Y. Development of experimental sporotrichosis in normal and modified animals. Mycopathologia 1981; 76: 79–82
   PubMed Web of Science ®Google Scholar
• Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4 + T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999; 37: 397–404
   PubMed Web of Science ®Google Scholar
• Arruda C, Kashino SS, Fazioli RA, Calich VL. A primary subcutaneous infection with Paracoccidioides brasiliensis leads to immunoprotection or exacerbated disease depending on the route of challenge. Microbes Infect 2007; 9: 308–316
   Google Scholar
• Gesztesi JL, Dias MA, de Souza AR, et al. Subcutaneous infection of mice with Paracoccidioides brasiliensis induces a peculiar pattern of inflammatory and immune responses. Mycopathologia 1999; 145: 7–14
   Google Scholar
• Belkaid Y, Mendez S, Lira R, et al. A natural model of Leishmania major infection reveals a prolonged “silent” phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 2000; 15: 969–977
   Google Scholar
• Peters N, Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 2006; 213: 159–179
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Immune privile: a recurrent theme in immunoregulation?. Immunol Rev 2006; 213: 5–11
   Google Scholar
• Schubach TM, Schubach A, Okamoto T, et al. Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998–2001). J Am Vet Med Assoc 2004; 224: 1623–1629
   PubMed Web of Science ®Google Scholar